CMPX compared with AVBP: revenue, margins and what each company keeps, and the suppliers and customers both name

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

AVBPArriVent BioPharma, Inc.

Mkt capRevenueRevenue

Compare

CMPXCompass Therapeutics, Inc.

AVBPArriVent BioPharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CMPX 5

—ABL Biounlistedsupplier

—Adimabunlistedsupplier

—B. Riley Securitiesunlistedsupplier

—Elpiscience Biopharmaceuticalsunlistedsupplier

1 more · CMPX chain ›

Shared 0

No shared counterparties.

Only AVBP 8

—Shanghai Allist Pharmaceuticalsunlistedsupplier

—Lepu Biopharmaunlistedsupplier

—Aarvik Therapeuticsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Jiangsu Alphamab Biopharmaceuticalsunlistedsupplier

4 more · AVBP chain ›

CMPXCompass Therapeutics, Inc.

0.77· pre 0.77· delayed

Mkt cap$141.6MRevenue$850,000Q2 FY24

AVBPArriVent BioPharma, Inc.

13.39· pre 13.85· delayed

Pre-marketNov 3 '26delayed

Mkt cap$707.9MRevenue—

Compare

Pre-marketNov 3 '26delayed

CMPXCompass Therapeutics, Inc.

AVBPArriVent BioPharma, Inc.

0.77pre 0.77delayed

Price

13.39pre 13.85delayed

$141.6M

Mkt cap

$707.9M

Q2 FY24$850,000

Revenue

—

CMPX0.77vsAVBP13.39Pre-marketNov 3 '26delayed